Bio-link Australia Pty. Ltd.

Client News

10/10/2017 – Oncology Venture’s pipeline continues to advance. Learn more about their drug candidates.

20/07/2017 – Oncology Venture receives option right to execute licence for clinical-stage cancer therapeutic from Novartismore

10/07/2017 – First Dosing in a Phase 1b Combination Trial of the Dynamin Inhibitor Prochlorperazinemore

07/06/2017 – Oncology Venture: new APO010 multiple myeloma trial initiation, clinical and patent strategy validation more